| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Keros Therapeutics, Inc. | Chief Science Officer | Common Stock | 31,127 | $508,926 | $16.35 | 18 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | 18 Feb 2026 | 1 | -$63,324 | 4 | Chief Science Officer | 20 Feb 2026, 16:15 |
| KROS | Keros Therapeutics, Inc. | 06 Aug 2025 | 0 | $0 | 3 | Chief Science Officer | 15 Aug 2025, 16:34 |